Development of a large-scale H3.3K27M-specific TCR-transduced T cell manufacturing method for adoptive cell therapy in HLA-A2+ patients with diffuse midline glioma.

K. Okada, A. Nguyen, P. Watchmaker, J. Xu, F. Ramsdell, J.H. Esensten, L.H. Butterfield, H. Okada. Development of a large-scale H3.3K27M-specific TCR-transduced T cell manufacturing method for adoptive cell therapy in HLA-A2+ patients with diffuse midline glioma. . 2019 May 1; 21(5):s36.

2019
https://researcherprofiles.org/profile/79291366

K. Okada, A. Nguyen, P. Watchmaker, J. Xu, F. Ramsdell, J.H. Esensten, L.H. Butterfield, H. Okada